These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 18516100
1. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Chiu J, Xu BY, Chen S, Feng B, Chakrabarti S. Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100 [Abstract] [Full Text] [Related]
2. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes. Xu B, Chiu J, Feng B, Chen S, Chakrabarti S. Diabetes Metab Res Rev; 2008 Jun; 24(5):404-12. PubMed ID: 18351623 [Abstract] [Full Text] [Related]
3. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. Minchenko AG, Stevens MJ, White L, Abatan OI, Komjáti K, Pacher P, Szabó C, Obrosova IG. FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290 [Abstract] [Full Text] [Related]
4. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. Wang C, George B, Chen S, Feng B, Li X, Chakrabarti S. Diabetes Metab Res Rev; 2012 May; 28(4):329-37. PubMed ID: 22228707 [Abstract] [Full Text] [Related]
6. Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300. Kaur H, Chen S, Xin X, Chiu J, Khan ZA, Chakrabarti S. Diabetes; 2006 Nov; 55(11):3104-11. PubMed ID: 17065349 [Abstract] [Full Text] [Related]
7. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Obrosova IG, Minchenko AG, Frank RN, Seigel GM, Zsengeller Z, Pacher P, Stevens MJ, Szabó C. Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016 [Abstract] [Full Text] [Related]
8. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Chen S, Feng B, George B, Chakrabarti R, Chen M, Chakrabarti S. Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E127-37. PubMed ID: 19903865 [Abstract] [Full Text] [Related]
9. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S. J Mol Cell Cardiol; 2000 Sep; 32(9):1621-9. PubMed ID: 10966825 [Abstract] [Full Text] [Related]
10. Endothelins: regulators of extracellular matrix protein production in diabetes. Khan ZA, Farhangkhoee H, Mahon JL, Bere L, Gonder JR, Chan BM, Uniyal S, Chakrabarti S. Exp Biol Med (Maywood); 2006 Jun; 231(6):1022-9. PubMed ID: 16741042 [Abstract] [Full Text] [Related]
11. Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP. Chandak PG, Gaikwad AB, Tikoo K. Phytother Res; 2009 Jan; 23(1):72-7. PubMed ID: 18693296 [Abstract] [Full Text] [Related]
12. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy. Adaikalakoteswari A, Rema M, Mohan V, Balasubramanyam M. Int J Biochem Cell Biol; 2007 Jan; 39(9):1673-84. PubMed ID: 17540609 [Abstract] [Full Text] [Related]
13. Akt activation and augmented fibronectin production in hyperhexosemia. Xin X, Chen S, Khan ZA, Chakrabarti S. Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1036-44. PubMed ID: 17666488 [Abstract] [Full Text] [Related]
14. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite. Radovits T, Zotkina J, Lin LN, Bömicke T, Arif R, Gerö D, Horváth EM, Karck M, Szabó C, Szabó G. Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528 [Abstract] [Full Text] [Related]
15. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB, Obrosova IG. Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320 [Abstract] [Full Text] [Related]
16. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Chen S, Khan ZA, Cukiernik M, Chakrabarti S. Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1089-97. PubMed ID: 12582013 [Abstract] [Full Text] [Related]
17. Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Arrick DM, Sharpe GM, Sun H, Mayhan WG. Microvasc Res; 2007 Jan; 73(1):1-6. PubMed ID: 16982071 [Abstract] [Full Text] [Related]
18. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C. Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240 [Abstract] [Full Text] [Related]
19. Oxidative stress-induced poly(ADP-ribosyl)ation in chick limb bud-derived chondrocytes. Zákány R, Bakondi E, Juhász T, Matta C, Szíjgyártó Z, Erdélyi K, Szabó E, Módis L, Virág L, Gergely P. Int J Mol Med; 2007 Apr; 19(4):597-605. PubMed ID: 17334635 [Abstract] [Full Text] [Related]
20. Poly(ADP-ribose) polymerase is involved in the development of diabetic cystopathy via regulation of nuclear factor kappa B. Li WJ, Shin MK, Oh SJ. Urology; 2011 May; 77(5):1265.e1-8. PubMed ID: 21496888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]